Related Experiment Video
Updated: Aug 6, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2
Hongguang Li1, Lihong Zhao2, Zhenhua Zhang1
11 Department of Thyroid Surgery, Henan Provincial People's Hospital, Zhengzhou, China.
Abstract:
The incidence of thyroid cancer has increased significantly in the last decade, and the most frequent type of this cancer is papillary thyroid carcinoma. MicroRNAs have been demonstrated to be abnormally expressed in tumors and associated with the development of the tumors. Our aim was to analyze the role and molecular mechanisms of tumor suppressor let-7b in the papillary thyroid carcinoma. Expression of let-7b and high-mobility group A2 in papillary thyroid carcinoma tissues and cell lines was assessed using quantitative reverse transcription polymerase chain reaction and western blot analysis. To explore the role of let-7b or high-mobility group A2 in the BCPAP and TPC-1 cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and Transwell methods were used. Let-7b expression was significantly downregulated while expression of high-mobility group A2 was upregulated dramatically in papillary thyroid carcinoma tissues and cells compared with that in normal thyroid tissues and cells. In addition, overexpression of let-7b or knockdown of high-mobility group A2 inhibited cell migration and invasion compared with that of control. Besides, high-mobility group A2 was negatively regulated by let-7b in BCPAP cells. Moreover, high-mobility group A2 reintroduction reversed the anti-proliferation, anti-migration, and anti-invasion roles of let-7b. Let-7b might function as a tumor suppressor in papillary thyroid carcinoma by suppressing the expression of high-mobility group A2, and therefore might provide a promising therapeutic target for patients with papillary thyroid carcinoma.
Insights
MicroRNA let-7b acts as a tumor suppressor in papillary thyroid carcinoma by downregulating high-mobility group A2. This finding offers a potential new therapeutic target for thyroid cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Thyroid cancer incidence is rising, with papillary thyroid carcinoma being the most common type.
- MicroRNAs are implicated in tumor development through abnormal expression patterns.
Purpose of the Study:
- To investigate the role and molecular mechanisms of the tumor suppressor microRNA let-7b in papillary thyroid carcinoma.
- To analyze the relationship between let-7b and high-mobility group A2 (HMGA2) in this cancer.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot to assess let-7b and HMGA2 expression.
- MTT and Transwell assays to evaluate cell proliferation, migration, and invasion.
- Gene manipulation (overexpression/knockdown) and reintroduction experiments in papillary thyroid carcinoma cell lines (BCPAP, TPC-1).
Main Results:
- Let-7b was significantly downregulated, while HMGA2 was upregulated in papillary thyroid carcinoma tissues and cells compared to normal controls.
- Overexpression of let-7b or knockdown of HMGA2 inhibited cancer cell migration and invasion.
- HMGA2 was negatively regulated by let-7b, and HMGA2 reintroduction reversed the suppressive effects of let-7b.
Conclusions:
- Let-7b functions as a tumor suppressor in papillary thyroid carcinoma by inhibiting HMGA2 expression.
- Let-7b and its regulatory pathway involving HMGA2 represent a promising therapeutic target for papillary thyroid carcinoma.
More Related Videos
Related Concept Videos
MicroRNAs
Master Transcription Regulators
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs

